No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination.
Autorzy:
Lu-Culligan A; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America. Tabachnikova A; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America. Pérez-Then E; Ministry of Health, Santo Domingo, Dominican Republic. Tokuyama M; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America.; Department of Microbiology and Immunology, The University of British Columbia, Vancouver, Canada. Lee HJ; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America. Lucas C; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America. Silva Monteiro V; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America. Miric M; Two Oceans in Health, Santo Domingo, Dominican Republic. Brache V; Biomedical Research Department, Profamilia, Santo Domingo, Dominican Republic. Cochon L; Biomedical Research Department, Profamilia, Santo Domingo, Dominican Republic. Muenker MC; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America. Mohanty S; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America.; Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America. Huang J; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America.; Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America. Kang I; Section of Rheumatology, Allergy and Immunology, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America. Dela Cruz C; Section of Pulmonary and Critical Care Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.; Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, Connecticut, United States of America. FarhadianS; Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America. Campbell M; Section of Pediatric Infectious Diseases, Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut, United States of America. Yildirim I; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.; Section of Pediatric Infectious Diseases, Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut, United States of America.; Yale Institute for Global Health, Yale University, New Haven, Connecticut, United States of America. Shaw AC; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America.; Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America. Ma S; Department of Biostatistics, Yale University, New Haven, Connecticut, United States of America. Vermund SH; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America. Ko AI; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.; Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America. Omer SB; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.; Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.; Yale Institute for Global Health, Yale University, New Haven, Connecticut, United States of America. Iwasaki A; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America.; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.; Department of Molecular, Cellular and Developmental Biology, New Haven, Connecticut, United States of America.; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America.
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2022 May 24; Vol. 20 (5), pp. e3001506. Date of Electronic Publication: 2022 May 24 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
